Lutein settlement
This article was originally published in The Tan Sheet
Executive Summary
Cognis, Kemin reach confidential settlement in litigation related to marketing of companies' respective Xangold lutein esters, FloraGLO lutein. Finalized Oct. 15, agreement clarifies how each company will market its products, with Kemin marketing its purified lutein as FloraGLO lutein and Cognis marketing its product as lutein esters. Pact settles Kemin's December 2001 lawsuit alleging Cognis failed to provide labeling guidelines recommending customers use a generic identifier other than "lutein" or "free lutein" for products containing Xangold (1"The Tan Sheet" Dec. 10, 2001, In Brief). Cognis countersued, alleging Kemin made false, misleading claims about both products...
You may also be interested in...
Kemin v. Cognis
FloraGLO lutein manufacturer Kemin sues Cognis in Des Moines, Iowa federal court Dec. 5, alleging Xangold lutein esters marketer failed to provide labeling guidelines - required under a court settlement - recommending customers use a generic identifier other than "lutein" or "free lutein" for their products. Kemin asserts Cognis has "embarked on an aggressive advertising campaign designed to mislead consumers as to the differences" between FloraGLO and Xangold. Cognis says it denies allegations and "believes Kemin has been making...false and misleading claims to the marketplace and its customers." Firms settled similar dispute in August 1999 (1"The Tan Sheet" Aug. 23, 1999, p. 14)...
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.